Influence of risk factors on insulin resistance in patients with overweight and obesity.

Wiad Lek

Department Of Therapy 1 And Medical Diagnostics, Faculty Of Postgraduate Education, Danylo Halytsky Lviv, National Medical University, Lviv, Ukraine.

Published: August 2018

Objective: Introduction: Obesity is a multifactorial, heterogenic disease, associated with an increased risk of morbidity and mortality due to cardiovascular diseases, diabetes, cancer, chronic liver and kidney diseases. Excessive body weight and obesity are serious medical and social problems, since their incidence is constantly increasing and has reached global epidemic proportions. The aim: Determining the influence of risk factors on insulin resistance level in patients with overweight and obesity.

Patients And Methods: Materials and methods: The study included 127 patients with overweight and obesity. Anthropometric measurement was performed for determination of the degree and type of obesity by WHO and IDF (2015) criteria. The levels of ALT, AST, uric acid, lipids, glucose, insulin, glycated hemoglobin in the blood were measured. HOMA-IR index was calculated and multiple regression method with inclusion of reliable signs was applied.

Results: Results: By multiple regression method, we identified four signs which, in combined action, affect HOMA-IR index: AST, triglycerides, insulin level and atorvastatin dose. Value of determination coefficient indicates that the level of insulin resistance in overweight and obese patients is by 37% explained by the factors included in regressive model. However, we did not investigate the influence of behavioral risk factors and burdened family history of type 2 diabetes mellitus, which significantly affect insulin resistance level.

Conclusion: Conclusions: We assume that modification of lifestyle and individual approach to pharmacologic correction of dyslipidemia in overweight and obese patients help to avoid the development of insulin resistance, which is a predictor of type 2 diabetes mellitus.

Download full-text PDF

Source

Publication Analysis

Top Keywords

insulin resistance
20
risk factors
12
patients overweight
12
influence risk
8
factors insulin
8
overweight obesity
8
multiple regression
8
regression method
8
overweight obese
8
obese patients
8

Similar Publications

Background: Accurate distinction between stroke etiologic subtypes is critical for physicians to provide tailored treatment. The triglyceride-glucose (TyG) index, a marker of insulin resistance, has been associated with stroke risk but its role in distinguishing stroke etiologic subtypes remains unclear. We aimed to assess the TyG index's ability to differentiate cardioembolic (CE) from non-cardioembolic (NCE) strokes.

View Article and Find Full Text PDF

Background: The triglycerides to Apolipoprotein A1 ratio (TG/APOA1) holds promise to be a more valuable index of insulin resistance for the diagnosis of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus (T2DM). This study aims to evaluate the correlation between TG/APOA1 and MAFLD, as well as compare the efficacy of TG/APOA1 with triglycerides to high-density lipoprotein cholesterol ratio (TG/HDL-c) and triglyceride-glucose (TyG) index in identifying MAFLD among individuals with T2DM.

Method: This study consecutively recruited 779 individuals with T2DM for the investigation.

View Article and Find Full Text PDF

Background: Body mass index (BMI) consistently correlates with the triglyceride-glucose (TyG) index, a marker of insulin resistance, which in turn is linked to heightened cardiovascular disease (CVD) risk. Thus, insulin resistance could potentially mediate the association between BMI and CVD risk. However, few studies have explored this mechanism in the general population.

View Article and Find Full Text PDF

The role of multimodality imaging in diabetic cardiomyopathy: a brief review.

Front Endocrinol (Lausanne)

December 2024

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States.

Diabetic cardiomyopathy (DMCM), defined as left ventricular dysfunction in the setting of diabetes mellitus without hypertension, coronary artery disease or valvular heart disease, is a well-recognized entity whose prevalence is certainly predicted to increase alongside the rising incidence and prevalence of diabetes mellitus. The pathophysiology of DMCM stems from hyperglycemia and insulin resistance, resulting in oxidative stress, inflammation, cardiomyocyte death, and fibrosis. These perturbations lead to left ventricular hypertrophy with associated impaired relaxation early in the course of the disease, and eventually culminating in combined systolic and diastolic heart failure.

View Article and Find Full Text PDF

Background: Type 2 Diabetes Mellitus (T2DM) is a significant public health burden. Emerging evidence links volatile organic compounds (VOCs), such as benzene to endocrine disruption and metabolic dysfunction. However, the effects of chronic environmentally relevant VOC exposures on metabolic health are still emerging.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!